Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understand how using tax lots for Dividend Etf losses can create precise tax benefits and align with your overall investment plan.
16,880 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
When the market tumbles, smart investors lean into durable industrials. This guide highlights two robust picks and a ...
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
Two oil giants enter 2026 with contrasting plays: Occidental Petroleum pares back, focusing on the Permian, while Exx...
Strategy faces a tough trade-off: use cash to back STRC dividends and buy Bitcoin, or raise fresh capital that dilute...
The market tops can be unsettling, but smart growth ideas endure. This guide highlights three compelling picks—Visa, ...
Investors face a pivotal choice in 2026: a dependable defense powerhouse or a cyclical recovery in commercial aviatio...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
SpaceX headlines grab attention, but smart investors look for durable earnings growth in established aerospace player...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...